{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:49:20Z","timestamp":1776127760518,"version":"3.50.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1016\/j.ygyno.2010.10.007","type":"journal-article","created":{"date-parts":[[2010,10,29]],"date-time":"2010-10-29T08:24:44Z","timestamp":1288340684000},"page":"73-83","source":"Crossref","is-referenced-by-count":9,"title":["Application of hTERC in thinprep samples with mild cytologic abnormality and HR-HPV positive"],"prefix":"10.1016","volume":"120","author":[{"given":"Ying","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Jie","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin-Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Guo","family":"L\u00fc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ding","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Hui","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xing","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9430","key":"10.1016\/j.ygyno.2010.10.007_bb0005","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0140-6736(04)16674-9","article-title":"The cervical cancer that screening has prevented in the UK","volume":"364","author":"Peto","year":"2004","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.ygyno.2010.10.007_bb0010","first-page":"701","article-title":"New technologies in gynecologic cytology","volume":"45","author":"Bishop","year":"2000","journal-title":"J Reprod Med"},{"issue":"2","key":"10.1016\/j.ygyno.2010.10.007_bb0015","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1067\/mob.2001.116736","article-title":"Liquid-based cervical cytologic smear study and conventional Papanicolaou smears: a metaanalysis of prospective studies comparing cytologic diagnosis and sample adequacy","volume":"185","author":"Bernstein","year":"2001","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ygyno.2010.10.007_bb0020","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0090-8258(03)00176-8","article-title":"Performance of ThinPrep liquid-based cervical cytology in comparison with conventionally prepared Papanicolaou smears: a quantitative survey","volume":"90","author":"Abulafia","year":"2003","journal-title":"Gynecol Oncol"},{"issue":"16","key":"10.1016\/j.ygyno.2010.10.007_bb0025","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1001\/jama.287.16.2114","article-title":"The 2001 Bethesda System\u2014terminology for reporting results of cervical cytology","volume":"287","author":"Solomon","year":"2002","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.ygyno.2010.10.007_bb0030","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1046\/j.1525-1381.1999.99723.x","article-title":"Papillomaviruses in human cancers","volume":"111","author":"zur Hausen","year":"1999","journal-title":"Proc Assoc Am Physicians"},{"issue":"Suppl 10","key":"10.1016\/j.ygyno.2010.10.007_bb0035","doi-asserted-by":"crossref","first-page":"K29","DOI":"10.1016\/j.vaccine.2008.06.019","article-title":"Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries","volume":"26","author":"Cuzick","year":"2008","journal-title":"Vaccine"},{"issue":"9399","key":"10.1016\/j.ygyno.2010.10.007_bb0040","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1016\/S0140-6736(03)14955-0","article-title":"Management of women who test positive for high-risk types of human papillomavirus: the HART study","volume":"362","author":"Cuzick","year":"2003","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ygyno.2010.10.007_bb0045","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1093\/jnci\/95.1.46","article-title":"Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis","volume":"95","author":"Sherman","year":"2003","journal-title":"J Natl Cancer Inst"},{"issue":"21","key":"10.1016\/j.ygyno.2010.10.007_bb0050","doi-asserted-by":"crossref","first-page":"10630","DOI":"10.1158\/0008-5472.CAN-06-1057","article-title":"The absolute risk of cervical abnormalities in high-risk human papillomavirus-positive, cytologically normal women over a 10-year period","volume":"66","author":"Kjaer","year":"2006","journal-title":"Cancer Res"},{"issue":"5","key":"10.1016\/j.ygyno.2010.10.007_bb0055","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1158\/1055-9965.EPI-07-2904","article-title":"A comparison of linear array and hybrid capture 2 for detection of carcinogenic HPV, and cervical precancer in ALTS","volume":"17","author":"Gravitt","year":"2008","journal-title":"Cancer Epidem Biomar"},{"issue":"8","key":"10.1016\/j.ygyno.2010.10.007_bb0060","doi-asserted-by":"crossref","first-page":"930","DOI":"10.5858\/2003-127-930-HPEAPH","article-title":"Human papillomavirus: epidemiology and public health","volume":"127","author":"Schiffman","year":"2003","journal-title":"Arch Pathol Lab Med"},{"issue":"7","key":"10.1016\/j.ygyno.2010.10.007_bb0065","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1056\/NEJM199802123380703","article-title":"Natural history of cervicovaginal papillomavirus infection in young women","volume":"338","author":"Ho","year":"1998","journal-title":"N Engl J Med"},{"issue":"9271","key":"10.1016\/j.ygyno.2010.10.007_bb0070","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/S0140-6736(00)04956-4","article-title":"Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study","volume":"357","author":"Woodman","year":"2001","journal-title":"Lancet"},{"issue":"21","key":"10.1016\/j.ygyno.2010.10.007_bb0075","doi-asserted-by":"crossref","first-page":"11451","DOI":"10.1128\/JVI.78.21.11451-11460.2004","article-title":"Mechanisms of human papilloma virus-induced oncogenesis","volume":"78","author":"M\u00fcnger","year":"2004","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.ygyno.2010.10.007_bb0080","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1073\/pnas.93.1.479","article-title":"Gain of chromosome 3q defines the transition from severe dysplasia to invasive carcinoma of the uterine cervix","volume":"93","author":"Heselmeyer","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"10.1016\/j.ygyno.2010.10.007_bb0085","doi-asserted-by":"crossref","first-page":"529","DOI":"10.2307\/3579618","article-title":"Telomeres, telomerase and chromosome stability","volume":"147","author":"Preston","year":"1997","journal-title":"Radiat Res"},{"issue":"2","key":"10.1016\/j.ygyno.2010.10.007_bb0090","first-page":"301","article-title":"Amplification of hTERT and hTERC genes in leukemic cells with high expression and activity of telomerase","volume":"16","author":"Nowak","year":"2006","journal-title":"Oncol Rep"},{"issue":"1","key":"10.1016\/j.ygyno.2010.10.007_bb0095","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ygyno.2008.01.040","article-title":"Gain of the 3q26 region in cervicovaginal liquid-based pap preparations is associated with squamous intraepithelial lesions and squamous cell carcinoma","volume":"110","author":"Caraway","year":"2008","journal-title":"Gynecol Oncol"},{"issue":"4","key":"10.1016\/j.ygyno.2010.10.007_bb0100","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/IGC.0b013e3181c50c7e","article-title":"Detection of human telomerase RNA gene in cervical cancer and precancerous lesions, comparison with cytological and human papillomavirus DNA test findings","volume":"20","author":"Li","year":"2010","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ygyno.2010.10.007_bb0105","first-page":"37","article-title":"Tumors of the cervix, vagina, and vulva","author":"Kurman","year":"1992","journal-title":"Atlas of Tumor Pathology. Armed Forces Inst Pathol"},{"issue":"2","key":"10.1016\/j.ygyno.2010.10.007_bb0110","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jcv.2004.02.008","article-title":"High risk HPV load estimated by Hybrid Capture II correlates with HPV16 load measured by real-time PCR in cervical smears of HPV16-infected women","volume":"31","author":"Pretet","year":"2004","journal-title":"J Clin Virol"},{"issue":"6","key":"10.1016\/j.ygyno.2010.10.007_bb0115","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1128\/JCM.42.6.2470-2475.2004","article-title":"Human papillomavirus testing with the hybrid capture 2 assay and PCR as screening tools","volume":"42","author":"Kulmala","year":"2004","journal-title":"J Clin Microbiol"},{"issue":"11","key":"10.1016\/j.ygyno.2010.10.007_bb0120","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1001\/jama.285.11.1500","article-title":"Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study","volume":"285","author":"Stoler","year":"2001","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.ygyno.2010.10.007_bb0125","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/dc.21194","article-title":"Comparison of the clinical significance of the Papanicolaou test interpretations LSIL cannot rule out HSIL and ASC-H","volume":"38","author":"Difurio","year":"2010","journal-title":"Diagn Cytopathol"},{"issue":"4","key":"10.1016\/j.ygyno.2010.10.007_bb0130","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.ajog.2007.07.047","article-title":"2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests","volume":"197","author":"Wright","year":"2007","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.ygyno.2010.10.007_bb0135","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/jnci\/92.5.397","article-title":"Human papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions: baseline data from a randomized trial","volume":"92","year":"2000","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"10.1016\/j.ygyno.2010.10.007_bb0140","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/jnci\/93.4.293","article-title":"Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial","volume":"93","author":"Solomon","year":"2001","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"10.1016\/j.ygyno.2010.10.007_bb0145","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1309\/JM3V-U4HP-W8HJ-68XV","article-title":"Qualification of ASCUS. A comparison of equivocal LSIL and equivocal HSIL cervical cytology in the ASCUS LSIL Triage Study","volume":"116","author":"Sherman","year":"2001","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.ygyno.2010.10.007_bb0150","doi-asserted-by":"crossref","unstructured":"Huh W, Einstein MH, Herzog TJ, Franco EL. What is the role of HPV typing in the United States now and in the next five years in a vaccinated population? Gynecol Oncol 2010 Jun;117(3):481\u20135.","DOI":"10.1016\/j.ygyno.2010.01.037"},{"key":"10.1016\/j.ygyno.2010.10.007_bb0155","series-title":"New strategies of cervical cancer screening","author":"Cuzick","year":"2010"},{"issue":"s1","key":"10.1016\/j.ygyno.2010.10.007_bb0160","doi-asserted-by":"crossref","first-page":"16--16","DOI":"10.1111\/j.1365-2303.2007.00500_8.x","article-title":"Detection of human telomerase gene (TERC) amplification in cervical neoplasia: a retrospective study of 50 patients with normal smears or mild or moderate dyskaryosis","volume":"18","author":"Crookes","year":"2007","journal-title":"Cytopathology"},{"issue":"8","key":"10.1016\/j.ygyno.2010.10.007_bb0165","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1111\/IGC.0b013e3181b62ea5","article-title":"Gain of the human telomerase RNA gene TERC at 3q26 is strongly associated with cervical intraepithelial neoplasia and carcinoma","volume":"19","author":"Sui","year":"2009","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2010.10.007_bb0170","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.cancergencyto.2009.01.004","article-title":"Genomic amplification of the human telomerase RNA gene for differential diagnosis of cervical disorders","volume":"191","author":"Tua","year":"2009","journal-title":"Cancer Genet Cytogen"},{"issue":"10","key":"10.1016\/j.ygyno.2010.10.007_bb0175","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1016\/j.humpath.2009.03.013","article-title":"3q26 (hTERC) gain studied by fluorescence in situ hybridization as a persistence-progression indicator in low-grade squamous intraepithelial lesion cases","volume":"40","author":"Alameda","year":"2009","journal-title":"Hum Pathol"},{"issue":"1","key":"10.1016\/j.ygyno.2010.10.007_bb0180","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ygyno.2009.03.031","article-title":"Gain of 3q26: a genetic marker in low-grade squamous intraepithelial lesions (LSIL) of the uterine cervix","volume":"114","author":"Seppo","year":"2009","journal-title":"Gynecol Oncol"},{"issue":"9328","key":"10.1016\/j.ygyno.2010.10.007_bb0185","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S0140-6736(02)09463-1","article-title":"Viral load of human papillomavirus and risk of CIN3 or cervical cancer","volume":"360","author":"Lorincz","year":"2002","journal-title":"Lancet"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825810007523?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825810007523?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,31]],"date-time":"2024-03-31T21:56:50Z","timestamp":1711922210000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825810007523"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["S0090825810007523"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2010.10.007","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]}}}